Lukas John

467 total citations
20 papers, 210 citations indexed

About

Lukas John is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Lukas John has authored 20 papers receiving a total of 210 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 9 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Lukas John's work include Multiple Myeloma Research and Treatments (14 papers), Chemokine receptors and signaling (3 papers) and Protein Degradation and Inhibitors (3 papers). Lukas John is often cited by papers focused on Multiple Myeloma Research and Treatments (14 papers), Chemokine receptors and signaling (3 papers) and Protein Degradation and Inhibitors (3 papers). Lukas John collaborates with scholars based in Germany, United States and Austria. Lukas John's co-authors include Niels Weinhold, Marc S. Raab, Maria Theresa Krauth, Marc‐Steffen Raab, Klaus Podar, Hartmut Goldschmidt, Alexandra M. Poos, Carsten Müller‐Tidow, Anja Baumann and Stephan M. Tirier and has published in prestigious journals such as Nature Communications, Blood and Cochrane Database of Systematic Reviews.

In The Last Decade

Lukas John

18 papers receiving 205 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lukas John Germany 6 125 113 89 51 26 20 210
Alexandra M. Poos Germany 6 131 1.0× 120 1.1× 92 1.0× 56 1.1× 24 0.9× 19 204
Jean-Baptiste Alberge United States 8 115 0.9× 133 1.2× 91 1.0× 41 0.8× 22 0.8× 24 213
Peter Tan Australia 10 126 1.0× 109 1.0× 55 0.6× 85 1.7× 11 0.4× 18 252
Xinyi Cindy Zhang United States 6 95 0.8× 68 0.6× 38 0.4× 112 2.2× 49 1.9× 7 247
Amanda R. Leonti United States 8 113 0.9× 99 0.9× 55 0.6× 35 0.7× 27 1.0× 32 193
Mary Ann Yancey United States 5 89 0.7× 152 1.3× 166 1.9× 25 0.5× 9 0.3× 11 227
Emily Labriola–Tompkins United States 6 45 0.4× 146 1.3× 59 0.7× 118 2.3× 10 0.4× 10 277
Sarah Deleu Belgium 6 150 1.2× 208 1.8× 95 1.1× 21 0.4× 22 0.8× 9 262
Lars Fransecky Germany 8 99 0.8× 131 1.2× 104 1.2× 33 0.6× 34 1.3× 14 267
Sandra Duquesne Germany 5 56 0.4× 109 1.0× 88 1.0× 108 2.1× 51 2.0× 5 256

Countries citing papers authored by Lukas John

Since Specialization
Citations

This map shows the geographic impact of Lukas John's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lukas John with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lukas John more than expected).

Fields of papers citing papers by Lukas John

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lukas John. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lukas John. The network helps show where Lukas John may publish in the future.

Co-authorship network of co-authors of Lukas John

This figure shows the co-authorship network connecting the top 25 collaborators of Lukas John. A scholar is included among the top collaborators of Lukas John based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lukas John. Lukas John is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kollmar, Martin, et al.. (2025). Investigating the bHLH transcription factor TSARL1 as marker and regulator of saponin biosynthesis in Chenopodium quinoa. Journal of the Science of Food and Agriculture. 105(13). 7329–7339.
2.
Grab, Anna Luise, Peter Kim, Lukas John, et al.. (2024). Pre-Clinical Assessment of SAR442257, a CD38/CD3xCD28 Trispecific T Cell Engager in Treatment of Relapsed/Refractory Multiple Myeloma. Cells. 13(10). 879–879. 5 indexed citations
3.
Langer, P., Lukas John, Ina Monsef, et al.. (2024). Daratumumab and antineoplastic therapy versus antineoplastic therapy only for adults with newly diagnosed multiple myeloma ineligible for transplant. Cochrane Database of Systematic Reviews. 2024(5). CD013595–CD013595. 8 indexed citations
4.
Sachpekidis, Christos, Lukas John, Peter Neher, et al.. (2024). Splenic T2 signal intensity loss on MRI is associated with disease burden in multiple myeloma. European Radiology. 35(6). 3576–3586.
5.
Kaudewitz, Dorothee, Lukas John, Jan Meis, et al.. (2024). Clinical and serological characterization of acute pleuropericarditis suggests an autoinflammatory pathogenesis and highlights risk factors for recurrent attacks. Clinical Research in Cardiology. 114(9). 1109–1117. 2 indexed citations
6.
John, Lukas, Sandra Sauer, Ute Hegenbart, et al.. (2023). Idecabtagene Vicleucel Is Well Tolerated and Effective in Relapsed/Refractory Myeloma Patients with Prior Allogeneic Stem Cell Transplantation. Transplantation and Cellular Therapy. 29(10). 609.e1–609.e6. 4 indexed citations
7.
Dittrich, Tobias, Martin Schorb, Niels Weinhold, et al.. (2023). High-throughput electron tomography identifies centriole over-elongation as an early event in plasma cell disorders. Leukemia. 37(12). 2468–2478. 2 indexed citations
8.
John, Lukas, Axel Benner, K. Elias, et al.. (2023). Impact of novel agent therapies on immune cell subsets and infectious complications in patients with relapsed/refractory multiple myeloma. Frontiers in Oncology. 13. 1078725–1078725. 2 indexed citations
9.
Sachpekidis, Christos, Olof Enqvist, Johannes Ulén, et al.. (2023). Application of an artificial intelligence-based tool in [18F]FDG PET/CT for the assessment of bone marrow involvement in multiple myeloma. European Journal of Nuclear Medicine and Molecular Imaging. 50(12). 3697–3708. 17 indexed citations
10.
Karg, Margarete M., Lukas John, Barbara C. Böck, et al.. (2022). Midkine Promotes Metastasis and Therapeutic Resistance via mTOR/RPS6 in Uveal Melanoma. Molecular Cancer Research. 20(8). 1320–1336. 4 indexed citations
11.
Schinke, Carolina, Alexandra M. Poos, Michael Bauer, et al.. (2022). Characterizing the role of the immune microenvironment in multiple myeloma progression at a single-cell level. Blood Advances. 6(22). 5873–5883. 34 indexed citations
12.
John, Lukas, Alexandra M. Poos, Stephan M. Tirier, et al.. (2021). The Spatial Heterogeneity in Newly Diagnosed Multiple Myeloma Patients - from Sub-Clonal Architecture to the Immune Microenvironment. Blood. 138(Supplement 1). 729–729. 3 indexed citations
13.
Tirier, Stephan M., Jan‐Philipp Mallm, Simon Steiger, et al.. (2021). Subclone-specific microenvironmental impact and drug response in refractory multiple myeloma revealed by single‐cell transcriptomics. Nature Communications. 12(1). 6960–6960. 78 indexed citations
14.
John, Lukas, Maria Theresa Krauth, Klaus Podar, & Marc‐Steffen Raab. (2021). Pathway-Directed Therapy in Multiple Myeloma. Cancers. 13(7). 1668–1668. 28 indexed citations
15.
Hirsch, Cassandra M., Vanessa Piechotta, Peter Langer, et al.. (2021). EFFICACY AND SAFETY OF DARATUMUMAB FOR THE TREATMENT OF MULTIPLE MYELOMA: A SERIES OF COCHRANE REVIEWS. Hematological Oncology. 39(S2). 2 indexed citations
16.
Poos, Alexandra M., Nicola Giesen, Nagarajan Paramasivam, et al.. (2020). Comprehensive Comparison of Early Relapse and End-Stage Relapsed Refractory Multiple Myeloma. Blood. 136(Supplement 1). 1–1. 4 indexed citations
17.
Tirier, Stephan M., Jan‐Philipp Mallm, Nicola Casiraghi, et al.. (2019). Dissecting Heterogeneity of Tumor Cells and Their Microenvironment in Refractory Multiple Myeloma. Blood. 134(Supplement_1). 571–571. 1 indexed citations
18.
Poos, Alexandra M., Jan‐Philipp Mallm, Stephan M. Tirier, et al.. (2019). A Comprehensive Analysis of Single-Cell Chromatin Accessibility and Gene Expression Identifies Intra-Tumor Heterogeneity and Molecular Treatment Responses in Relapsed/Refractory Multiple Myeloma. Blood. 134(Supplement_1). 575–575. 2 indexed citations
19.
Ahmad, Rozilawati, et al.. (2017). Immobilisation precision in VMAT for oral cancer patients. Journal of Physics Conference Series. 851. 12025–12025. 1 indexed citations
20.
Liu, T.-J., Dorothy Taylor, M Wang, et al.. (1997). Head and neck squamous cell growth suppression using adenovirus-p53-FLAG: a potential marker for gene therapy trials.. PubMed. 3(2). 185–91. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alexandra M. Poos Breakdown of academic impact, for papers by Jean-Baptiste Alberge Breakdown of academic impact, for papers by Peter Tan Breakdown of academic impact, for papers by Xinyi Cindy Zhang Breakdown of academic impact, for papers by Amanda R. Leonti Breakdown of academic impact, for papers by Mary Ann Yancey Breakdown of academic impact, for papers by Emily Labriola–Tompkins Breakdown of academic impact, for papers by Sarah Deleu Breakdown of academic impact, for papers by Lars Fransecky Breakdown of academic impact, for papers by Sandra Duquesne
Rankless by CCL
2026